News | March 03, 2025
Glenmark Pharmaceuticals acquires and launches acetylcysteine injection
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
The PIPE offering consists of 36,190,476 units
We have big plans across our B2C and B2B businesses in India and abroad
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Standalone profit from operations for Q4-2024 were Rs. 108 crore
USFDA inspection at Emcure Pharmaceuticals API facility
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
Subscribe To Our Newsletter & Stay Updated
